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Introduction
Cerebral malaria (CM) is a severe complication of 
Plasmodium falciparum infection. Despite effective 
antimalarial drugs, 10–20% of children developing CM die, 
contributing to 400,000 malarial deaths per year, mostly in 
children in sub-Saharan Africa.1,2 A defining feature of CM 
is the cytoadherence of P falciparum-infected erythrocytes 
(IE) to vascular endothelial cells and their sequestration 
in the microvasculature, which is observed by retinopathy. 
Microvascular thrombosis and blood–brain barrier 
breakdown are key components of CM pathogenesis.3,4 
We have previously demonstrated that elevated circulating 
histones, released from damaged host cells, bind to cell 
membranes and cause coagulation activation, platelet 
aggregation, microvascular thrombosis and vascular leak 
in critically ill patients.5–8 The aim of this study was to 
investigate whether histones are released from parasites to 
play a pathological role in CM.
Materials and methods
Children aged 6 months – 16 years were recruited at Queen 
Elizabeth Central Hospital, Blantyre, Malawi between January 
2010 and August 2011; inclusion criteria were described 
previously.9 Children who met World Health Organization 
criteria for CM underwent funduscopic examination by 
an ophthalmologist: characteristic retinal changes are 
strongly associated with sequestration of IE in the brain and 
distinguish children with stringently defined retinopathy-
positive (ret-pos) CM from those with retinopathy-negative 
(ret-neg) CM, to which malaria makes a variable contribution 
to coma aetiology.1 Healthy controls were children attending 
elective surgery. Circulating histones were quantified by 
Western blot, and mass spectrometry was used to determine 
the origin of histones. Endothelial toxicity and leakage assays 
were performed using primary human brain microvascular 
endothelial cells. Magnetic resonance imaging (MRI) images 
acquired on admission were scored independently by two 
radiologists, blinded to patient details.3 Formalin-fixed 
post-mortem brain tissues from Malawian children with fatal 
encephalopathic illness were collected and stained for histones 
and fibrinogen.
Results and discussion
Using Western blot and mass spectrometry, we demonstrate 
that extracellular histones are significantly elevated in the 
circulation of CM patients compared with controls, with 
over 50% released from parasites. Circulating histones were 
significantly elevated in ret-pos CM compared with ret-
neg CM. Serum from patients with ret-pos CM or purified 
P falciparum histones are toxic to cultured human brain 
endothelial cells and cause disruption of barrier function. 
This can be reversed by anti-histone antibodies and non-
anticoagulant heparin. On post-mortem brain sections of 
patients with CM, we found that histones are co-localised 
with P falciparum parasites sequestrated within the brain 
vasculature, suggesting that histones may be locally released 
from parasitic breakdown. Histone staining on the luminal 
vascular surface is strongly associated with thrombosis and 
leakage, indicating coagulation activation and endothelial 
disruption. High levels of circulating histones were 
significantly associated with the extent of brain swelling 
on MRI, providing further clinical evidence for the role of 
histones in this process.
Conclusion
Our data strongly suggest that parasite histones play key roles 
in thrombosis and swelling in the brain, processes implicated in 
the causal pathway to death in CM. Neutralising histones with 
agents such as non-anticoagulant heparin holds great promise 
to prevent the development of CM and reduce mortality of 
children with malaria. n
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